Rs. 162
Rs. 170.60
 5% off

Diovol Oral Solution Mango Sugar Free

(170 ml Oral Solution in bottle)
Diovol Oral Solution Mango Sugar Free
Product Details

Diovol Oral Solution Mango Sugar Free is an antacid and antiflatulent oral suspension formulated to help manage symptoms of acidity and gas. The suspension is sugar-free, comes in a pleasant mango flavour, and combines aluminium hydroxide, magnesium hydroxide, activated dimethicone, and sorbitol solution to provide fast-acting relief from acidity, heartburn, and gas.

Key Ingredients:
Each 5ml contains:

Aluminium Hydroxide Paste equivalent to Dried Aluminium Hydroxide I.P. 250 mg, Magnesium Hydroxide Paste equivalent to Magnesium Hydroxide I.P. 250 mg, Activated Dimethicone I.P. 50 mg, Sorbitol Solution (70%) I.P. (Non - Crystallising) 1.25 g, Colour: Tartrazine, Sunset Yellow FCF

Key Benefits:

  • Acts as a fast-acting antacid to help manage excess stomach acid

  • Provides antiflatulent action to help ease gas and abdominal fullness

  • Sugar-free formulation suitable for individuals monitoring their sugar intake

  • Pleasant mango flavour makes oral consumption easier


Good to Know:
Sugar-free formula with mango flavour

Concerns It Can Help With:

  • Acidity

  • Gas and flatulence

  • Heartburn

  • Indigestion


Product Form:
Oral Solution

Dosage:
As directed by the Physician.

Net Qty:
170 ml

Directions for Use:
Dosage: As directed by the Physician.

Safety Information:

  • Protect from light

  • Do not freeze

  • Store below 30°C

  • Keep out of the reach of children

  • SHAKE WELL BEFORE USE


Quick Tips:
Shake the bottle well before each use to ensure uniform dispersion of ingredients.

Frequently Asked Question:-
Q: What is Diovol Oral Solution used for?
A: It is a fast-acting antacid and antiflatulent suspension used to help manage acidity, heartburn, and gas.

Q: How should Diovol Oral Solution be stored?
A: Store below 30°C, protect from light, and do not freeze. Keep out of reach of children.


Content on this page was last updated on 18 November, 2026, by Dr. Rajeev Sharma (MBA, MBBS)